FDA NDC Directory · JSON-LD · Markdown
NDC 0310-9400 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION
| Generic name | EPLONTERSEN |
|---|---|
| Labeler / Manufacturer | AstraZeneca Pharmaceuticals LP |
| Marketing category | New Drug Application (innovator) · App NDA217388 |
| Dosage form / route | INJECTION, SOLUTION · SUBCUTANEOUS |
| Active ingredients | EPLONTERSEN (45 mg/.8mL) |
| Marketing started | 20231221 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).